Medixant RadiAnt DICOM Viewer 2024.02 certificate validation
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability classified as critical has been found in Medixant RadiAnt DICOM Viewer 2024.02. Affected is an unknown function. This manipulation causes certificate validation. The identification of this vulnerability is CVE-2025-1001. The attack needs to be done within the local network. There is no exploit available.
Details
A vulnerability was found in Medixant RadiAnt DICOM Viewer 2024.02. It has been declared as problematic. Affected by this vulnerability is some unknown processing. The manipulation with an unknown input leads to a certificate validation vulnerability. The CWE definition for the vulnerability is CWE-295. The product does not validate, or incorrectly validates, a certificate. As an impact it is known to affect integrity. The summary by CVE is:
Medixant RadiAnt DICOM Viewer is vulnerable due to failure of the update mechanism to verify the update server's certificate which could allow an attacker to alter network traffic and carry out a machine-in-the-middle attack (MITM). An attacker could modify the server's response and deliver a malicious update to the user.
The weakness was shared with Sharon Brizinov as icsma-25-051-01. The advisory is shared at cisa.gov. This vulnerability is known as CVE-2025-1001 since 02/03/2025. The exploitation appears to be difficult. Access to the local network is required for this attack to succeed. The exploitation doesn't need any form of authentication. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1587.003 for this issue.
The vulnerability scanner Nessus provides a plugin with the ID 216941 (RadiAnt DICOM Viewer (CVE-2025-1001)), which helps to determine the existence of the flaw in a target environment.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at Tenable (216941). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CNA CVSS-B Score: 🔍
CNA CVSS-BT Score: 🔍
CNA Vector: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.3
VulDB Base Score: 3.1
VulDB Temp Score: 3.0
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 5.7
CNA Vector (icscert): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Certificate validationCWE: CWE-295 / CWE-287
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 216941
Nessus Name: RadiAnt DICOM Viewer (CVE-2025-1001)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/03/2025 🔍02/21/2025 🔍
02/21/2025 🔍
02/28/2025 🔍
Sources
Advisory: icsma-25-051-01Organization: Sharon Brizinov
Status: Not defined
CVE: CVE-2025-1001 (🔍)
GCVE (CVE): GCVE-0-2025-1001
GCVE (VulDB): GCVE-100-296449
Entry
Created: 02/21/2025 07:36Updated: 02/28/2025 20:34
Changes: 02/21/2025 07:36 (76), 02/28/2025 20:34 (2)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.